Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,957 total articles
High Roller Technologies, a publicly traded online gaming and prediction markets company, announced the completion and winners of its eight-week ROLR Free-To-Trade Prediction Challenge held from June 2 through August 12, 2026. Michael D. Franz was named Season Champion and awarded $75,000 after finishing first on the leaderboard. The competition se…
Cre8 Enterprise Limited, a financial printing service provider based in Hong Kong and listed on Nasdaq, announced record customer numbers and project backlog as of mid-2026, driven by increased regional capital market activity, notably a surge in IPO filings to the Hong Kong Stock Exchange. The company is optimistic about future demand and aims to …
Syntec Optics Holdings, Inc. (NASDAQ: OPTX), a leading manufacturer of high-precision optics and photonics, announced a new recurring order to build specialized waveguides for communication satellites. The company is scaling production to meet urgent demand from a top-tier customer, strengthening its position in the expanding space economy. Financi…
Rail Vision Ltd. achieved significant commercial momentum in the first half of 2026, with revenues surpassing $1 million, a 328% increase from the prior year period. Key achievements include integration of its ShuntingYard technology into Railserve’s YardGUARD system in the U.S., successful field testing with Israel Railways, and continued global b…
Abercrombie & Fitch Co. announced record net sales of $1.3 billion for Q2 fiscal 2026, marking the 15th consecutive quarter of growth with sales increases across all regions, led by an 8% rise in the Abercrombie brand. Operating margin reached 20%, and EPS was $4.17, outperforming prior outlook partly due to a $100 million IEEPA tariff refund benef…
BridgeBio Pharma has initiated dosing of the first participant in ASCEND-ATTR, a Phase 3b/4 clinical study designed to assess the long-term effects of acoramidis, an oral transthyretin stabilizer, on cardiac structure, function, and amyloid burden in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Building on prior Phase 3 ATTRibute-C…
Eikon Therapeutics, a late-stage clinical biopharmaceutical company focusing on oncology and innovative drug development, announced its participation in two key healthcare investor conferences in September 2026. The company's CEO and CFO will engage in fireside chats to discuss business strategies and recent progress. The company leverages propriet…
Trevi Therapeutics, a clinical-stage biopharmaceutical company listed on Nasdaq (TRVI), announced acceptance of two abstracts for presentations at the ERS Congress 2026 in Barcelona. The presentations focus on quality-of-life outcomes from their Phase 2b CORAL and Phase 2a RIVER trials evaluating their investigational therapy, oral nalbuphine exten…
Repligen Corporation announced its planned participation at the Wells Fargo 21st Annual Healthcare Conference, where its CEO and CFO will engage in an analyst-led discussion. The company continues to emphasize its role in developing innovative bioprocessing technologies primarily for biopharmaceutical developers and CDMOs.
Brandywine Realty Trust announced the expiration of its tender offer to repurchase up to $70 million of its outstanding 8.875% guaranteed notes due 2029. Approximately 50.1% of the notes were tendered, resulting in $70 million accepted and purchased at a premium price. The purchase will be funded by cash on hand and/or borrowings, aiming to retire …
Nexera Technologies announces that its majority-owned subsidiary Fort Technology has completed the acquisition of 50.1% of Logia USA, a company specializing in advanced fuel integrity solutions for data centers and other critical facilities in the US. This acquisition positions Fort Technology to capitalize on the growing data center market expecte…
Fort Technology Inc. has completed the acquisition of a majority stake (50.1%) in Logia USA Inc., a company specializing in advanced fuel integrity solutions targeting data centers and mission-critical facilities in the United States. This acquisition supports Fort's strategic expansion into the US data center market, leveraging Logia USA's technol…
Super Hi International Holding Ltd., operator of international Haidilao hot pot restaurants, announced unaudited Q2 2026 financial results showing a 10% increase in revenue to $218.8 million and a near doubling of income from operations margin to 3.7%. The company expanded its restaurant network by 2 outlets reaching 129 stores and grew delivery an…
Dycom Industries, Inc., a leading specialty contractor for telecommunications infrastructure and utilities, announced a new $150 million stock repurchase program authorized by its Board of Directors. The program aims to repurchase shares over the next eighteen months through various transaction methods and replaces a previous program. This move ref…
AIR Global PLC announced the approval of multiple proposals at its Extraordinary General Meeting, including a $52.45 million share repurchase of 5 million shares from Harraden Circle Investors and authorizations for future share repurchases. Shareholders also approved amendments to the company’s articles of association governing meeting notices, ai…
Photronics, Inc. reported its Q3 fiscal 2026 results, showing a 2.7% year-over-year revenue increase to $216 million, driven by recovering semiconductor design releases and strong fab utilization. IC revenue rose by 5%, while flat panel display revenue declined slightly. GAAP net income increased to $28.9 million ($0.49/share). The company remains …
INmune Bio has submitted regulatory filings to the European Medicines Agency seeking Orphan Drug Designation and scientific advice for Ebstrocel™, a pooled allogeneic umbilical cord-derived mesenchymal stromal cell therapy developed for recessive dystrophic epidermolysis bullosa (RDEB). These steps support the company’s planned EU Marketing Authori…
G-III Apparel Group, a prominent global fashion company owning and licensing many well-known brands, will release its Q2 fiscal 2027 earnings on September 2, 2026, and host a conference call for investors. The company highlights its diverse brand portfolio and notes risks related to licensing, supply chain, economic environment, and competitive pre…
Veea Inc. (NASDAQ: VEEA) announced a new collaboration with Totalplay Telecomunicaciones to offer Veea's AI-powered SecureConnect and VigiLynx services to Totalplay's business customers in Mexico. The partnership integrates Veea's cloud-managed edge platform with Totalplay’s extensive fiber-optic network and managed services. This collaboration bui…
Senmiao Technology Limited has officially changed its name to Valor Energy Inc. and updated its Nasdaq ticker from AIHS to VAI. This rebranding signifies the company's strategic pivot from automobile-related services in China to developing digital infrastructure and energy projects in the U.S., focusing on AI and high-performance computing power-en…
Electra Battery Materials Corporation has finalized a C$17.5 million funding agreement with Invest Ontario to support the construction of North America's first cobalt sulfate refinery in Temiskaming Shores, Ontario. The refinery is expected to start commercial production by the fourth quarter of 2027, producing battery-grade cobalt sulfate and redu…
Auddia Inc. announced that its CEO, Jeff Thramann, will be interviewed on Fox Business' Varney & Co. to discuss the LT350 distributed datacenter strategy—a modular AI data center infrastructure integrated into parking lot canopies. Concurrently, Auddia plans to merge with Thramann Holdings to form McCarthy Finney, an AI native operating company, le…
Sound Group Inc. reported a 25% increase in net revenues to US$249.2 million and a 78% surge in net income to US$17.8 million for the first half of 2026. Subscription revenues, driven by the expansion of AI-powered applications, soared 245% year-over-year, validating the company's dual-engine growth strategy focusing on global AI business expansion…
Radiopharm Theranostics has dosed the first patient in the second cohort of its Phase 1/2a clinical trial for RV-01 (177Lu-Betabart), a radiopharmaceutical targeting B7-H3 expressing solid tumors. The trial aims to evaluate safety, biodistribution, and preliminary anti-tumor efficacy, progressing after a positive safety recommendation. This marks a…
Ligand Pharmaceuticals announced that its senior management team will participate in key investor conferences in September 2026, including the Wells Fargo Healthcare Conference, Citi Biopharma Back to School Conference, and H.C. Wainwright Global Investment Conference. Management will conduct fireside chats and one-on-one meetings to discuss the co…
